• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prognostic risk factors analysis of low-grade gastric intraepithelial neoplasia-a single-center follow-up study.低级别胃上皮内瘤变的预后危险因素分析——一项单中心随访研究
Front Med (Lausanne). 2025 Aug 29;12:1637102. doi: 10.3389/fmed.2025.1637102. eCollection 2025.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia.治疗寻常型外阴上皮内瘤变的医学和外科干预措施。
Cochrane Database Syst Rev. 2016 Jan 5;2016(1):CD011837. doi: 10.1002/14651858.CD011837.pub2.
4
Medical interventions for high-grade vulval intraepithelial neoplasia.高级别外阴上皮内瘤变的医学干预措施。
Cochrane Database Syst Rev. 2015 Aug 18;2015(8):CD007924. doi: 10.1002/14651858.CD007924.pub3.
5
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
6
Are There Sex Differences in the Association of Alcohol Consumption With the Risk of Soft Tissue Sarcoma? A Nationwide Population-based Study in Korea.饮酒与软组织肉瘤风险之间的关联存在性别差异吗?韩国一项基于全国人口的研究。
Clin Orthop Relat Res. 2025 Jun 25. doi: 10.1097/CORR.0000000000003602.
7
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
8
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
9
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
10
[Clinical and endoscopic features of autoimmune gastritis with gastric neoplastic lesions].[自身免疫性胃炎合并胃肿瘤性病变的临床及内镜特征]
Zhonghua Nei Ke Za Zhi. 2025 Jul 1;64(7):652-659. doi: 10.3760/cma.j.cn112138-20241008-00660.

本文引用的文献

1
ACG Clinical Guideline: Diagnosis and Management of Gastric Premalignant Conditions.美国胃肠病学会临床指南:胃癌前病变的诊断与管理
Am J Gastroenterol. 2025 Apr 1;120(4):709-737. doi: 10.14309/ajg.0000000000003350. Epub 2025 Mar 12.
2
Natural products based on Correa's cascade for the treatment of gastric cancer trilogy: Current status and future perspective.基于科雷亚级联反应的天然产物用于胃癌三部曲治疗:现状与未来展望。
J Pharm Anal. 2025 Feb;15(2):101075. doi: 10.1016/j.jpha.2024.101075. Epub 2024 Aug 19.
3
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.美国胃肠病学会临床指南:幽门螺杆菌感染的治疗
Am J Gastroenterol. 2024 Sep 1;119(9):1730-1753. doi: 10.14309/ajg.0000000000002968. Epub 2024 Sep 4.
4
The road to a world-unified approach to the management of patients with gastric intestinal metaplasia: a review of current guidelines.通向胃黏膜肠上皮化生患者管理的全球统一方法之路:当前指南综述。
Gut. 2024 Sep 9;73(10):1607-1617. doi: 10.1136/gutjnl-2024-333029.
5
Global, regional, and national burden of early-onset gastric cancer.全球、区域和国家早发性胃癌负担。
Cancer Biol Med. 2024 Aug 7;21(8):667-78. doi: 10.20892/j.issn.2095-3941.2024.0159.
6
Global incidence and mortality trends of gastric cancer and predicted mortality of gastric cancer by 2035.全球胃癌发病率和死亡率趋势以及到 2035 年预测的胃癌死亡率。
BMC Public Health. 2024 Jul 2;24(1):1763. doi: 10.1186/s12889-024-19104-6.
7
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
8
Chinese national clinical practice guidelines on the prevention, diagnosis, and treatment of early gastric cancer.中国早期胃癌防治国家临床实践指南
Chin Med J (Engl). 2024 Apr 20;137(8):887-908. doi: 10.1097/CM9.0000000000003101. Epub 2024 Mar 21.
9
Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention.全球胃癌负担:流行病学趋势、风险因素、筛查和预防。
Nat Rev Clin Oncol. 2023 May;20(5):338-349. doi: 10.1038/s41571-023-00747-0. Epub 2023 Mar 23.
10
Helicobacter pylori World Gastroenterology Organization Global Guideline.《幽门螺杆菌世界胃肠病学组织全球指南》
J Clin Gastroenterol. 2023 Feb 1;57(2):111-126. doi: 10.1097/MCG.0000000000001719.

低级别胃上皮内瘤变的预后危险因素分析——一项单中心随访研究

Prognostic risk factors analysis of low-grade gastric intraepithelial neoplasia-a single-center follow-up study.

作者信息

Jiang Xin, Miao Ziting, Chen Xuyu, Xia Jianlei, Zhou Bengang, Chen Yuanyuan, Fang Jingwen, She Qiang, Li Yaoyao, Zhang Min, Ding Yanbing

机构信息

Department of Gastroenterology, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China.

出版信息

Front Med (Lausanne). 2025 Aug 29;12:1637102. doi: 10.3389/fmed.2025.1637102. eCollection 2025.

DOI:10.3389/fmed.2025.1637102
PMID:40950955
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12425926/
Abstract

OBJECTIVE

Low-grade gastric intraepithelial neoplasia (LGIN), as a precancerous lesion of gastric cancer, is of great significance in the prevention and treatment of gastric cancer. In this study, we investigated the risk factors associated with LGIN through the follow-up of LGIN patients, and provided a reliable basis for the clinical management of LGIN patients and the formulation of individualized clinical diagnosis and treatment strategies.

METHODS

A total of 283 patients, newly diagnosed with LGIN, were enrolled in the study. The regression of LGIN among these patients was assessed by comparing their gastroscopic and pathological findings before and after a rigorous follow-up period. The cohort was then stratified into a progressive group and a non-progressive group. Univariate analysis and multivariate logistic regression analysis were employed to investigate the potential risk factors contributing to the progression of LGIN in these patients.

RESULTS

Among 283 LGIN patients, 8.1% demonstrated lesion progression. Notably, five cases progressed to adenocarcinoma, resulting in an overall cancer incidence rate of 1.8%. Various factors, including age, gender, family history of gastrointestinal tumors, history of alcohol consumption, preference for pickled foods, preference for strong tea, infection, lesion location, and endoscopic lesion manifestation, were found to be correlated with the progression of LGIN ( < 0.05). Multifactorial logistic regression analysis further elucidated that a history of alcohol consumption ( = 0.022, OR = 3.224, 95% CI: 1.183-8.782), a family history of gastrointestinal tumors ( = 0.029, OR = 3.526, 95% CI: 1.136-10.947), combined with infection ( = 0.024, OR = 4.220, 95% CI: 1.205-14.783), lesion location in the cardia/gastric fundus ( = 0.004, OR = 6.838, 95% CI: 1.874-24.958), and endoscopic manifestation of an ulcerated indurated type ( = 0.023, OR = 5.073, 95% CI: 1.245-20.667) emerged as significant risk factors for lesion progression in LGIN patients.

CONCLUSION

LGIN patients with a history of alcohol consumption, a family history of gastrointestinal tumors, a combination of infection, and lesions located in the cardia/gastric fundus versus lesions endoscopically presenting as ulcerated depressions are more likely to progress to cancer. These risk factors provide a reliable basis for the clinical management of LGIN patients and the development of individualized clinical treatment strategies.

摘要

目的

低度胃上皮内瘤变(LGIN)作为胃癌的癌前病变,在胃癌防治中具有重要意义。本研究通过对LGIN患者的随访,探讨与LGIN相关的危险因素,为LGIN患者的临床管理及个体化临床诊疗策略的制定提供可靠依据。

方法

共纳入283例新诊断为LGIN的患者。通过比较严格随访前后的胃镜及病理结果,评估这些患者中LGIN的转归情况。然后将队列分为进展组和非进展组。采用单因素分析和多因素logistic回归分析,研究这些患者中导致LGIN进展的潜在危险因素。

结果

283例LGIN患者中,8.1%出现病变进展。值得注意的是,5例进展为腺癌,总体癌症发生率为1.8%。发现年龄、性别、胃肠道肿瘤家族史、饮酒史、喜食腌制食品、喜饮浓茶、感染、病变部位及内镜下病变表现等多种因素与LGIN的进展相关(P<0.05)。多因素logistic回归分析进一步表明,饮酒史(P=0.022,OR=3.224,95%CI:1.183-8.782)、胃肠道肿瘤家族史(P=0.029,OR=3.526,95%CI:1.136-10.947)、合并感染(P=0.024,OR=4.220,95%CI:1.205-14.783)、病变位于贲门/胃底(P=0.004,OR=6.838,95%CI:1.874-24.958)以及内镜下表现为溃疡硬结型(P=0.023,OR=5.073,95%CI:1.245-20.667)是LGIN患者病变进展的重要危险因素。

结论

有饮酒史、胃肠道肿瘤家族史、合并感染且病变位于贲门/胃底以及内镜下表现为溃疡凹陷的LGIN患者更易进展为癌症。这些危险因素为LGIN患者的临床管理及个体化临床治疗策略的制定提供了可靠依据。